Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00304681Phase 3Completed
A Phase 3 trial of methylphenidate-OROS in attention deficit hyperactivity disorder (ADHD), sponsored by Janssen Ortho. Status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00304681.